top of page

Q2 warning letter roundup with Asa Waldstein

Asa Waldstein

Jul 11, 2023

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

bottom of page